Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

Share Price is delayed by 15 minutes
Get Live Data
98.90    -1.20 (-1.20%)
Bid:
99.22
Ask:
99.28
Spread: 0.06 (0.06%)
Market Cap: £57.64b
LLOY Live PriceLast checked at - London Stock Exchange

Intraday Lloyds Share Chart

Issue of Equity

2 Mar 2026 16:25

RNS Number : 9942U
Lloyds Banking Group PLC
02 March 2026
 

2 March 2026

 

LLOYDS BANKING GROUP PLC - NOTIFICATION OF ISSUANCE OF EQUITY SECURITIES

 

On 19 January 2026, Lloyds Banking Group plc (the "Company") announced details of its ordinary shares of 10p each ("Shares") that had been block listed under the historic UK Listing Rules block listing regime for the purposes of satisfying share plan awards and that remained unallotted as at that date (the "Unallotted Shares"). Further to that announcement, the Company announces the allotment and issuance of 220,314,633 Unallotted Shares between 19 January 2026 and 27 February 2026 (inclusive) to satisfy awards under the Company's share plans and their admission to trading on the Main Market of the London Stock Exchange under the Company's existing block admissions of Shares for this purpose (as detailed in the table below).

This notification covers the period of 19 January 2026 to 27 February 2026 (inclusive).

 

1

Details of the issuer

a)

Name

Lloyds Banking Group plc

b)

LEI

549300PPXHEU2JF0AM85

2

Details of the transferable securities admitted to trading

a)

Name, type and identification code

Ordinary Shares of 10p each

GB0008706128

b)

Regulated market

London Stock Exchange - Main Market

c)

Number of further Shares issued and admitted to trading

220,314,633 (19 January 2026 to 27 February 2026 (inclusive))

(admitted under block admissions dated 2 March 2022, 22 November 2023, 27 November 2024, 22 May 2025, 24 November 2025)

d)

Number of Shares admitted to trading following the further issuance set out in 2 c)

59,029,409,081 (as at close of business on 27 February 2026)

(80,689,090 Unallotted Shares (not yet in issue) remain subject to the block admissions dated 27 November 2024, 22 May 2025 and 24 November 2025) 

e)

Fungibility

Fully fungible with existing ordinary shares

3

Issue and admission details

a)

Dates of issuance and admission

19 January 2026 to 27 February 2026 (inclusive)

(admitted under block admissions dated 2 March 2022, 22 November 2023, 27 November 2024, 22 May 2025, 24 November 2025)

b)

Prospectus information

Not applicable

 

- END -

ENQUIRIES:

 

Investor Relations

Douglas Radcliffe

Group Investor Relations Director

Email: douglas.radcliffe@lloydsbanking.com

 

Group Corporate Affairs

Matt Smith

Head of Media Relations

Email: matt.smith@lloydsbanking.com

 

+44 (0) 20 7356 1571

 

 

 

+44 (0) 7788 352 487

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEQLLFBQXLLBBL
Date   Source Headline
10th Dec 20254:39 pmRNSDirector/PDMR Shareholding
9th Dec 20254:00 pmRNSDirector/PDMR Shareholding
9th Dec 20257:03 amRNSCompletion of £1.7 billion Share Buyback Programme
8th Dec 20255:42 pmRNSTransaction in Own Shares
5th Dec 20255:50 pmRNSTransaction in Own Shares
4th Dec 20255:38 pmRNSTransaction in Own Shares
3rd Dec 20255:44 pmRNSTransaction in Own Shares
2nd Dec 20255:35 pmRNSTransaction in Own Shares
2nd Dec 20257:39 amRNSBoE Stress Test Passed
1st Dec 20255:31 pmRNSTransaction in Own Shares
28th Nov 20254:12 pmRNSTotal Voting Rights
27th Nov 20255:34 pmRNSTransaction in Own Shares
26th Nov 20255:38 pmRNSTransaction in Own Shares
25th Nov 20255:20 pmRNSTransaction in Own Shares
24th Nov 20255:41 pmRNSTransaction in Own Shares
21st Nov 20255:43 pmRNSTransaction in Own Shares
21st Nov 20253:00 pmRNSDirector/PDMR Shareholding
20th Nov 20255:28 pmRNSTransaction in Own Shares
20th Nov 20253:00 pmRNSBlock Listing of Shares
19th Nov 20255:38 pmRNSTransaction in Own Shares
19th Nov 20251:20 pmRNSDirector Declaration
19th Nov 20257:00 amRNSCurve Acquisition
18th Nov 20255:35 pmRNSTransaction in Own Shares
17th Nov 20255:40 pmRNSTransaction in Own Shares
14th Nov 20255:53 pmRNSTransaction in Own Shares
13th Nov 20255:27 pmRNSTransaction in Own Shares
12th Nov 20255:32 pmRNSTransaction in Own Shares
11th Nov 20255:33 pmRNSTransaction in Own Shares
11th Nov 20253:40 pmRNSDirector/PDMR Shareholding
10th Nov 20255:35 pmRNSTransaction in Own Shares
7th Nov 20255:42 pmRNSTransaction in Own Shares
6th Nov 20255:39 pmRNSTransaction in Own Shares
6th Nov 20252:33 pmRNSPublication of Final Terms
6th Nov 202510:32 amRNSDirector/PDMR Shareholding
5th Nov 20255:34 pmRNSTransaction in Own Shares
4th Nov 20255:42 pmRNSTransaction in Own Shares
3rd Nov 20255:45 pmRNSTransaction in Own Shares
31st Oct 20255:47 pmRNSTransaction in Own Shares
31st Oct 20254:38 pmRNSTotal Voting Rights
30th Oct 20255:16 pmRNSTransaction in Own Shares
29th Oct 20255:40 pmRNSTransaction in Own Shares
29th Oct 202510:31 amRNSNotification of Redemption
28th Oct 20255:29 pmRNSTransaction in Own Shares
27th Oct 20255:29 pmRNSTransaction in Own Shares
24th Oct 20255:56 pmRNSTransaction in Own Shares
24th Oct 202511:33 amRNSPublication of Suppl.Prospcts
24th Oct 20259:30 amRNSPublication of Suppl.Prospcts
23rd Oct 20255:49 pmRNSTransaction in Own Shares
23rd Oct 202512:25 pmRNSPublication of Suppl.Prospcts
23rd Oct 202511:58 amRNS2025 Q3 Interim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.